argipressin--des-glynh2(9)- and Amnesia

argipressin--des-glynh2(9)- has been researched along with Amnesia* in 2 studies

Trials

2 trial(s) available for argipressin--des-glynh2(9)- and Amnesia

Article	Year
A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man. Progress in neuro-psychopharmacology & biological psychiatry, 1985, Volume: 9, Issue:3 In a double-blind cross-over trial the memory effect of the neuropeptide desglycinamide arginine vasopressin (DGAVP) was selected because of its well-documented facilitatory effects on memory components in rodents. Patients with stabilized or progressive amnesic disorders (Korsakoff disease, early stages of Alzheimer dementia, head injuries and other central nervous system diseases) did not respond to the drug. Factors possibly explaining the discrepancy with animal research are discussed. Topics: Adult; Aged; Amnesia; Arginine Vasopressin; Clinical Trials as Topic; Cognition; Double-Blind Method; Female; Humans; Intelligence Tests; Learning; Male; Memory; Memory Disorders; Middle Aged; Oxytocin; Random Allocation; Vasopressins	1985
Desmopressin and desglycinamide vasopressin in post-traumatic amnesia. Lancet (London, England), 1981, Jan-03, Volume: 1, Issue:8210 Topics: Administration, Intranasal; Amnesia; Arginine Vasopressin; Clinical Trials as Topic; Craniocerebral Trauma; Deamino Arginine Vasopressin; Humans	1981

Article

Year

A clinical trial with desglycinamide arginine vasopressin for the treatment of memory disorders in man.

Progress in neuro-psychopharmacology & biological psychiatry, 1985, Volume: 9, Issue:3

In a double-blind cross-over trial the memory effect of the neuropeptide desglycinamide arginine vasopressin (DGAVP) was selected because of its well-documented facilitatory effects on memory components in rodents. Patients with stabilized or progressive amnesic disorders (Korsakoff disease, early stages of Alzheimer dementia, head injuries and other central nervous system diseases) did not respond to the drug. Factors possibly explaining the discrepancy with animal research are discussed.

Topics: Adult; Aged; Amnesia; Arginine Vasopressin; Clinical Trials as Topic; Cognition; Double-Blind Method; Female; Humans; Intelligence Tests; Learning; Male; Memory; Memory Disorders; Middle Aged; Oxytocin; Random Allocation; Vasopressins

1985

Desmopressin and desglycinamide vasopressin in post-traumatic amnesia.

Lancet (London, England), 1981, Jan-03, Volume: 1, Issue:8210

Topics: Administration, Intranasal; Amnesia; Arginine Vasopressin; Clinical Trials as Topic; Craniocerebral Trauma; Deamino Arginine Vasopressin; Humans

1981